Ocumension Therapeutics

HKEX:1477.HK

5.41 (HKD) • At close November 5, 2024
Bedrijfsnaam Ocumension Therapeutics
Symbool 1477.HK
Munteenheid HKD
Prijs 5.43
Beurswaarde 4,370,930,085
Dividendpercentage 0%
52-weken bereik 4.13 - 7.94
Industrie Biotechnology
Sector Healthcare
CEO Mr. Ye Liu
Website https://www.ocumension.com

An error occurred while fetching data.

Over Ocumension Therapeutics

Ocumension Therapeutics, together with its subsidiaries, operates as an ophthalmic pharmaceutical platform company in the People's Republic of China. The company discovers, develops, and commercializes therapies for ophthalmic patients. It offers drugs for the treatment of blepharitis, infective and allergic conjunctivitis, dry eye, cataract, glaucoma and ocular hypertension, postoperative inflammation,

Vergelijkbare Aandelen

Tong Ren Tang Technologies Co. Ltd. logo

Tong Ren Tang Technologies Co. Ltd.

1666.HK

5.22 HKD

Yidu Tech Inc. logo

Yidu Tech Inc.

2158.HK

3.81 HKD

New Horizon Health Limited logo

New Horizon Health Limited

6606.HK

14.14 HKD

Kangji Medical Holdings Limited logo

Kangji Medical Holdings Limited

9997.HK

5.98 HKD

The United Laboratories International Holdings Limited logo

The United Laboratories International Holdings Limited

3933.HK

10.82 HKD

Beijing Tong Ren Tang Chinese Medicine Company Limited logo

Beijing Tong Ren Tang Chinese Medicine Company Limited

3613.HK

8.34 HKD

Alphamab Oncology logo

Alphamab Oncology

9966.HK

3.87 HKD

Luye Pharma Group Ltd. logo

Luye Pharma Group Ltd.

2186.HK

2.8 HKD

Beijing Chunlizhengda Medical Instruments Co., Ltd. logo

Beijing Chunlizhengda Medical Instruments Co., Ltd.

1858.HK

12.7 HKD

China Isotope & Radiation Corporation logo

China Isotope & Radiation Corporation

1763.HK

11.58 HKD

Financiële Gegevens

Cijfers zijn in miljoenen (HKD)

Cijfers zijn in miljoenen (HKD)